Berkenblit, Anna <br/><br/>
A6, a urokinase plasminogen activator (uPA)-derived peptide in patients with advanced gynecologic cancer: a phase I trial.  [electronic resource] 

 -  Gynecologic oncology  Oct 2005 
 - 50-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>0090-8258 
<br/><br/><label>Standard No.: </label>10.1016/j.ygyno.2005.05.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Amino Acid Sequence<br/>Antineoplastic Agents--administration & dosage<br/>Biomarkers, Tumor--blood<br/>Dose-Response Relationship, Drug<br/>Female<br/>Genital Neoplasms, Female--blood<br/>Humans<br/>Injections, Subcutaneous<br/>Middle Aged<br/>Molecular Sequence Data<br/>Peptide Fragments--administration & dosage<br/>Urokinase-Type Plasminogen Activator--administration & dosage